TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
EDIT

Editas Medicine Inc

Healthcare · Biotechnology

2.70$ +0.4% vs. previous close Closing price · As of: Sep 17, 2026

Investor relations

Report Dates

Investor relations overview for Editas Medicine Inc (EDIT): report dates, earnings surprises, earnings call transcripts and the latest headlines. The next report is scheduled for 11/09/2026.

Next report 11/09/2026
Last report 08/05/2026
Earnings surprise by quarter (%)
Q3 23 · 5.2 % 23 Q4 23 · 57.4 % 23 Q1 24 · -18.8 % 24 Q2 24 · -15.5 % 24 Q3 24 · 2.6 % 24 Q4 24 · -67.4 % 24 Q1 25 · -55.9 % 25 Q2 25 · 15.8 % 25 Q3 25 · 26.3 % 25 Q4 25 · 73.9 % 25 Q1 26 · -8.3 % 26 Q2 26 · 50.0 % 26

EPS estimate beaten

Full history 23 of 43 quarters (53%)
Last 16 quarters 10 of 16 quarters (63%)

Earnings Call Transcripts

Search all transcripts →

No transcripts yet — they will show up here automatically after the next earnings call.

News on This Stock

  • 08/05/2026 Editas Medicine, Inc. (EDIT): Results of Operations and Financial Condition; Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Financial Statements and Exhibits · sec.gov Open ↗

Automatically matched wire and portal stories; external links open the original source.

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q) · Transcripts: transcript archive

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?